Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP754839.RATFR6_-y8SJJOOVPL26F8fCpGJB-QmkjKIKNEiYFsHpo130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP754839.RATFR6_-y8SJJOOVPL26F8fCpGJB-QmkjKIKNEiYFsHpo130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP754839.RATFR6_-y8SJJOOVPL26F8fCpGJB-QmkjKIKNEiYFsHpo130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP754839.RATFR6_-y8SJJOOVPL26F8fCpGJB-QmkjKIKNEiYFsHpo130_provenance.
- NP754839.RATFR6_-y8SJJOOVPL26F8fCpGJB-QmkjKIKNEiYFsHpo130_assertion description "[Current pharmacologic treatment of IBD, including 5-aminosalycylate, steroids, and immunomodulator therapy, are mainly aimed at suppressing inflammation non-specifically, except biologic therapies such as anti-tumor necrosis factor molecule, which block specific proinflammatory molecules.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP754839.RATFR6_-y8SJJOOVPL26F8fCpGJB-QmkjKIKNEiYFsHpo130_provenance.
- NP754839.RATFR6_-y8SJJOOVPL26F8fCpGJB-QmkjKIKNEiYFsHpo130_assertion evidence source_evidence_literature NP754839.RATFR6_-y8SJJOOVPL26F8fCpGJB-QmkjKIKNEiYFsHpo130_provenance.
- NP754839.RATFR6_-y8SJJOOVPL26F8fCpGJB-QmkjKIKNEiYFsHpo130_assertion SIO_000772 19647622 NP754839.RATFR6_-y8SJJOOVPL26F8fCpGJB-QmkjKIKNEiYFsHpo130_provenance.
- NP754839.RATFR6_-y8SJJOOVPL26F8fCpGJB-QmkjKIKNEiYFsHpo130_assertion wasDerivedFrom befree-2016 NP754839.RATFR6_-y8SJJOOVPL26F8fCpGJB-QmkjKIKNEiYFsHpo130_provenance.
- NP754839.RATFR6_-y8SJJOOVPL26F8fCpGJB-QmkjKIKNEiYFsHpo130_assertion wasGeneratedBy ECO_0000203 NP754839.RATFR6_-y8SJJOOVPL26F8fCpGJB-QmkjKIKNEiYFsHpo130_provenance.
- befree-2016 importedOn "2016-02-19" NP754839.RATFR6_-y8SJJOOVPL26F8fCpGJB-QmkjKIKNEiYFsHpo130_provenance.